跳至主要内容
临床试验/ISRCTN25655161
ISRCTN25655161已完成不适用

Crossover randomised controlled trial studying the effects of chocolate with and without polyphenols in type 2 diabetes

Hull and East Yorkshire Hospitals NHS Trust (UK)0 个研究点目标入组 20 人开始时间: 2009年9月22日最近更新:

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Both males and females, ages 18 and above
  • 2. Type 2 diabetes
  • 3. Stable medication

排除标准

  • Changes in medication over the past 3 months

研究者

发起方
Hull and East Yorkshire Hospitals NHS Trust (UK)

相似试验

尚未招募
1 期
A randomized cross-over controlled trial study on the regulation of gut microbiota by traditional Chinese medicine of the four properties(cold, hot, warm and cool )Healthy people
ITMCTR2200006140Dongzhimen Hospital, Beijing University of Chinese Medicine
暂停
不适用
Myopia Progression and Orthokeratology Lens WearProgressing mild late-onset myopiaEye - Diseases / disorders of the eye
ACTRN12606000054516Dr Helen Owens, Senior Lecturer, Department of Optometry, University of Auckland50
已完成
不适用
VEgetableS for vaScular hEaLth: The VESSEL StudyBlood pressureGlycemic controlInflammationOxidative stressArterial stiffnessCardiovascular - Normal development and function of the cardiovascular systemMetabolic and Endocrine - Normal metabolism and endocrine development and functionInflammatory and Immune System - Normal development and function of the immune system
ACTRN12619001294145Edith Cowan University21
进行中(未招募)
1 期
Ambulatory Oxygen in Fibrotic Lung DiseaseFibrotic Lung Diseases (FLDs) are chronic and progressive conditions resulting in substantial morbidity and mortality. The cardinal symptom of all fibrotic Interstitial Lung Diseases (ILDs) is shortness of breath. Although initially present only on strenuous activities, this unfortunately progresses until even routine activities of daily living become severely limited. This has a devastating impact on Quality of Life (QOL).MedDRA version: 16.1Level: PTClassification code 10022611Term: Interstitial lung diseaseSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disorders
EUCTR2013-004355-20-GBRoyal Brompton and Harefield NHS Foundation Trust
已完成
不适用
Investigating the effect of the AIRVO on arterial carbon dioxide (PaCO2) in patients with stable Chronic Obstructive Pulmonary Disease (COPD).Chronic Obstructive Pulmonary DiseaseRespiratory - Chronic obstructive pulmonary disease
ACTRN12615000471583Medical Research Institute of New Zealand48